BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10095444)

  • 21. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
    Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
    Miettinen M; Sobin LH; Sarlomo-Rikala M
    Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of prognostic markers in brain tumors.
    Grzybicki DM; Moore SA
    Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in malignant gastrointestinal stromal tumors.
    Muro-Cacho CA; Cantor AB; Morgan M
    Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic assessment of gastrointestinal stromal tumor.
    Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
    Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological analysis of gastrointestinal stromal tumors.
    Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
    Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal tumors of the stomach. Review of our experience and reclassification of a series of patients.
    Cuberes R; Rivera T; Picardo A; Martínez-Peñalver I; Medina M; Jara A; Alias D; de la Plaza R; Pacheco E; Suárez A
    Rev Esp Enferm Dig; 2000 Jan; 92(1):13-26. PubMed ID: 10749594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
    Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
    Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current classification of gastrointestinal stromal tumors].
    Hillemanns M; Höfler H
    Chirurg; 2000 Nov; 71(11):1327-34. PubMed ID: 11132318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):493-501. PubMed ID: 18223480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
    Rudolph P; Chiaravalli AM; Pauser U; Oschlies I; Hillemanns M; Gobbo M; Marichal M; Eusebi V; Höfler H; Capella C; Klöppel G
    Virchows Arch; 2002 Sep; 441(3):238-48. PubMed ID: 12242520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological features and clinical course of the gastrointestinal stromal tumors.
    Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
    Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
    Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
    Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
    Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
    Gleason BC; Fletcher CD
    Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histopathological and cytological findings in a case of gastrointestinal stromal tumor presenting in the pelvic cavity].
    Takekawa Y; Kimura M; Sakakibara M; Yoshii R; Yamashita Y
    Rinsho Byori; 2007 Jun; 55(6):535-9. PubMed ID: 17657986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nonrandom association between gastrointestinal stromal tumors and myeloid leukemia.
    Miettinen M; Kraszewska E; Sobin LH; Lasota J
    Cancer; 2008 Feb; 112(3):645-9. PubMed ID: 18041070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.